EME Equity Market – October 2024 A red October for the EME indices, only Czechia in positive territory. The MSCI EM Europe Index declined by 6.0% in EUR terms and 8.4% in USD terms in October. The Czech PX index was the only one spared, adding 1.3% mom in EUR terms. Türkiye was battered the most, with the Turkish ISE30 declining by 7.3% mom in EUR terms, followed closely by the Polish WIG20 (-6.7% mom in EUR terms). Greece fell 4.8% mom in EUR terms, while the Hungarian BUX index lost 2.7% mom i...
>Q2 2024-25 results below expectations - AT&S this morning reported its Q2 2024-25 results which beat expectations on sales/adjusted EBITDA but fell short on net profit and operating CF. Sales were € 451m, above the company-compiled consensus at € 423m. They were flat y-o-y and up 29% q-o-q. Adjusted EBITDA was € 127m, i.e. a margin of 28.1%, above the consensus at € 106m and 25%. Net profit was -€ 29m, below the consensus at -€ 10m, due notably to high start-up cos...
>Q2 2024-25 results below expectations - AT&S this morning reported its Q2 2024-25 results which beat expectations on sales/adjusted EBITDA but fell short on net profit and operating CF. Sales were € 451m, above the company-compiled consensus at € 423m. They were flat y-o-y and up 29% q-o-q. Adjusted EBITDA was € 127m, i.e. a margin of 28.1%, above the consensus at € 106m and 25%. Net profit was -€ 29m, below the consensus at -€ 10m, due notably to high start-up cos...
HEADLINES: • Erste Bank: 3Q24 results – strong NII delivery • mBank: underlying 3Q34 business delivery in line; beat on headline net profit due to tax charges NEUTRAL • ING BSK: 3Q24 results – minor miss on high credit risk charges, as corporate NPL ratio surges NEUTRAL • Jeronimo Martins: beat in 3Q24, Biedronka at -2% lfl and stable margin erosion; price war continues POSITIVE • Komercni Banka: 3Q24 results – net profit largely in line with expectations • Medicover: 3Q24 operating numbers in l...
EQS-News: Andritz AG / Schlagwort(e): 9-Monatszahlen/Quartalsergebnis ANDRITZ verzeichnet solide Entwicklung im dritten Quartal 2024 31.10.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. GRAZ, 31. OKTOBER 2024. Der internationale Technologiekonzern ANDRITZ verzeichnete im dritten Quartal 2024 trotz des weiterhin herausfordernden wirtschaftlichen Umfelds eine solide Geschäftsentwicklung. Während sich der Auftragseingang im Vergleich zum dritten Quartal 2023 erhöhte, blieb die Rentabilität (EBITA-Marge) stabil und der Umsat...
EQS-News: Andritz AG / Key word(s): 9 Month figures/Quarter Results ANDRITZ reports solid development in Q3 2024 31.10.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. GRAZ, OCTOBER 31, 2024 International technology group ANDRITZ reported solid business development in the third quarter of 2024 despite the continuously challenging economic environment. While order intake increased from the third quarter of 2023, profitability (EBITA margin) remained stable, and revenue declined slightly. The increase in order intake was driven by...
EQS-News: AT&S Austria Technologie & Systemtechnik AG / Schlagwort(e): Halbjahresergebnis/Quartals-/Zwischenmitteilung AT&S erwartet Umsatz auf Vorjahresniveau 31.10.2024 / 07:03 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. AT&S erwartet Umsatz auf Vorjahresniveau Umsatz im 2. Quartal 2024/25 mit 451 Mio. € um 29 % höher als im Vorquartal und auf dem gleichen Niveau wie im Vorjahresquartal (Q2 2023/24: 452 Mio. €; Q1 2024/25: 349 Mio. €) Ausblick für GJ 2024/25 aufgrund der Marktlage angepasst Ausblick für GJ 2026/27 bestä...
EQS-News: AT&S Austria Technologie & Systemtechnik AG / Key word(s): Half Year Results/Quarterly / Interim Statement AT&S expects revenue at prior-year level 31.10.2024 / 07:03 CET/CEST The issuer is solely responsible for the content of this announcement. AT&S expects revenue at prior-year level Revenue in Q2 2024/25 € 451 million, up 29% on Q1 2024/25 and at the same level as prior-year quarter (Q2 2023/24: € 452 million; Q1 2024/25: € 349 million) Outlook for FY 2024/25 adjusted due to market situation Outlook for FY 2026/27 confirmed Leoben – AT&S expects ...
Temenos, the European leader in core banking solutions with significant market share with Tier 3, 4 and 5 banks, faces structural challenges that impair its growth outlook: 1/ the reticence of major banking groups to renew their core banking system; 2/ fierce competition in the digital segment; and 3/ the slowdown in the launch pace for new neo-banks. Indeed, the group is set to scale back its medium-term targets at its CMD on 12 November. Moreover, the support for the stock offered b...
Temenos, leader européen des solutions Core Banking avec une part de marché significative auprès des banques Tiers 3, 4 et 5, fait face des défis structurels qui réduisent ses perspectives de croissance : 1/ la réticence des grands acteurs bancaires à renouveler leur Core banking system; 2/ la forte compétition sur le segment Digital et 3/ le ralentissement du rythme de lancement de nouvelles néo-banques. Aussi, le groupe devrait abaisser ses objectifs MT lors du CMD du 12 novembre. E...
>Underperformance rating reiterated following a PW raising questions about the investment case and liquidity risk - Target price adjusted to € 15 (vs € 19) - Yesterday, AT&S announced a new profit warning linked to a number of issues (pricing pressure, volatile orders from one customer, weakness of auto/industry, delay in the ramp-up of the AMD fab). We are lowering our EBITDA by ~10% over the next three years and adjusting our target price to €15 (DCF + multiple) vs ...
>Underperformance rating reiterated following a PW raising questions about the investment case and liquidity risk - Target price adjusted to € 15 (vs € 19) - Yesterday, AT&S announced a new profit warning linked to a number of issues (pricing pressure, volatile orders from one customer, weakness of auto/industry, delay in the ramp-up of the AMD fab). We are lowering our EBITDA by ~10% over the next three years and adjusting our target price to €15 (DCF + multiple) vs ...
HEADLINES: • Footshop (FTSHP CP): a sneakerhead’s dream – soft coverage (NOT RATED) • Poland macro: weaker consumption boosts prospects for early rate cuts • Sarantis: 3Q trading update in line, FY24E guidance maintained NEUTRAL • Hungary macro: MNB signals a longer pause • PKO BP: CEO Midera gives the gist of key strategic directions in Puls Biznesu interview NEUTRAL • Wirtualna Polska: Wakacje.pl and Itaka extend cooperation NEUTRAL • Metlen Energy & Metals: 9M24 trading update preview (due ou...
>A fresh acceleration to worldwide semiconductor sales in August at +20.6% y-o-y (vs +18.7% in July) - Worldwide semiconductor sales in August 2024 were published by the WSTS (World Semiconductor Trade Statistics) with the usual one-month lag. On a three-month moving average, sales came to $ 53.1bn, ahead of our forecast of $ 52bn. This represents a sequential increase of 3.5% and +20.6% y-o-y, after +18.7% in July. At the regional level, sales from one year to the n...
>Nouvelle accélération de la croissance des ventes mondiales de semis en août à +20.6% yoy (vs +18.7% en juillet) - Les ventes mondiales de semiconducteurs d’août 2024 ont été publiées par WSTS (World Semiconductor Trade Statistics), avec (comme toujours) un mois de décalage. En données lissées (moyenne de 3 mois), elles ressortent à 53.1 Md$ au-dessus de notre prévision à 52 Md$. Il s’agit d’une hausse séquentielle de 3.5% et annuelle de 20.6% après 18.7% en juillet....
Last week we held our fourth ODDO BHF Iberian Forum. The event was fully virtual and took place on October 1 and 2. With 62 Iberian issuers, close to 200 institutional investors and c. 800 meetings, this is one of the largest dedicated Iberian conferences held this year. This note brings together 49 feedback documents, with 5 target price revisions (o/w 3 downward revisions) and a rating downgrade on Pharma Mar. The main subjects of debate were i/ the trend in final demand in the con...
Last week we held our fourth ODDO BHF Iberian Forum. The event was fully virtual and took place on October 1 and 2. With 62 Iberian issuers, close to 200 institutional investors and c. 800 meetings, this is one of the largest dedicated Iberian conferences held this year. This note brings together 49 feedback documents, with 5 target price revisions (o/w 3 downward revisions) and a rating downgrade on Pharma Mar. The main subjects of debate were i/ the trend in final demand in the con...
Last week we held our fourth ODDO BHF Iberian Forum. The event was fully virtual and took place on October 1 and 2. With 62 Iberian issuers, close to 200 institutional investors and c. 800 meetings, this is one of the largest dedicated Iberian conferences held this year. This note brings together 49 feedback documents, with 5 target price revisions (o/w 3 downward revisions) and a rating downgrade on Pharma Mar. The main subjects of debate were i/ the trend in final demand in the con...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.